Profile
AVR ABT BSX-PA BSX SYK MDT
Company Name Anteris Technologies Global Corp. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $184.73M $223.47B $175.45B $150.72B $129.62B $107.94B
Employees 0.14K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Wayne Geoffrey Paterson Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
AVR ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
AVR ABT BSX-PA BSX SYK MDT
Last Close $4.98 $128.85 $122.18 $101.9 $365.06 $84.16
High 52 $8.78 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $2.47 $100.07 $122.18 $71.87 $315.94 $76.84
Price vs. 52 Week High -43.28 % -8.11 % 0 % -4.03 % -8.71 % -10.94 %
Price vs. 52 Week Low 101.62 % 28.76 % 0 % 41.78 % 15.55 % 9.53 %
Total Return
AVR ABT BSX-PA BSX SYK MDT
1 Month Return 7.1 % 1.77 % 0 % -0.43 % -0.74 % -4.61 %
3 Month Return -16.86 % 3.06 % 0 % -0.04 % -7.42 % -6.69 %
6 Month Return 0 % 12.81 % 0 % 20.26 % 3.47 % -7.1 %
9 Month Return 0 % 22.43 % 0 % 36.01 % 10.07 % 6.94 %
YTD Return -10.75 % 13.92 % 0 % 14.08 % 1.39 % 5.36 %
1 Year Return 0 % 19.83 % 0 % 39.26 % 8.78 % 5.54 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AVR ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.77 % - - 0.97 % 3.33 %
Dividend Paid and Capex Coverage Ration (TTM) -26.87 % 1.42 % 3.37 % 3.37 % 2.15 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.62 % 1.24 % 1.13 % 40.73 % 84.62 %
Profitability
AVR ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 46.84 % 55.59 % 67.02 % 67.15 % 62.84 % 62.89 %
Return on Assets TTM -94.54 % 16.46 % 4.7 % 5.16 % 6.97 % 4.73 %
Return on Equity TTM -415.88 % 32.37 % 8.94 % 9.82 % 15.02 % 8.69 %
Return on Capital Employed TTM -122.19 % 10.32 % 8.63 % 9.32 % 10.75 % 7.74 %
Net Income Per EBT TTM 100.43 % 191.1 % 81.07 % 81.97 % 85.71 % 81.56 %
EBT Per Ebit TTM 96.93 % 101.01 % 80.13 % 80.59 % 91.89 % 86.39 %
EBIT Per Revenue TTM -2899.45 % 16.55 % 17.01 % 17.52 % 16.82 % 18.21 %
Cash Flow To Debt Ratio TTM -4390.04 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Receivables Turnover TTM 7.06 4.42 6.55 6.86 5.67 5.43
Payables Turnover TTM 0.24 4.44 5.75 6.01 5 5.39
Inventory Turnover TTM 2.8 3.01 1.97 2.05 1.76 2.2
Fixed Asset Turnover TTM 46.13 % 393.6 % 447.28 % 468.83 % 655.31 % 503.55 %
Asset Turnover TTM 3.35 % 51.53 % 42.51 % 44.56 % 52.58 % 36.9 %
Operating Cash Flow Per Share TTM -2.6 4.94 2.33 2.33 11.13 5.69
Free Cash Flow Per Share TTM -2.69 3.67 1.66 1.65 9.15 4.26
Cash Per Share TTM 298.84 % 460.07 % 28.12 % 28.03 % 1155.38 % 617.75 %
Operating Cash Flow Sales Ratio TTM -2265.67 % 20.4 % 20.51 % 19.57 % 18.77 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.72 % 74.21 % 70.98 % 70.98 % 82.2 % 74.96 %
Cash Flow Coverage Ratios TTM -4390.04 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Price To Free Cash Flows Ratio TTM -1.86 35.19 57.79 61.82 37.17 19.74
Price To Operating Cash Flows Ratio TTM -1.23 26.07 40.82 43.82 30.5 14.8
Price Cash Flow Ratio TTM -1.23 26.07 40.82 43.82 30.5 14.8
Income Statement (TTM)
AVR ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $0B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 46.84% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.08B $10.83B $2.6B $2.6B $5.72B $8.2B
Net Income $-0.08B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -3.77 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
AVR ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.97B $8.97B $0B $24.77B
Total Liabilities $0.02B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $0.06B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.75B $8.34B
Total Debt $0B $15.02B $10.75B $10.75B $1.41B $26.05B
Total Assets $0.08B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
AVR ABT BSX-PA BSX SYK MDT
Net Income $-0.08B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $-0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.06B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 128.85
ADGM Adagio Medical Holdings, Inc. 1.3
AEMD Aethlon Medical, Inc. 0.3813
AFIB Acutus Medical, Inc. 0.041
AHCO AdaptHealth Corp. 8.41
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 183.35
ALUR Allurion Technologies Inc. 2.4
AMIX Autonomix Medical, Inc. Common Stock 2.08
ANIK Anika Therapeutics, Inc. 14.43
AORT Artivion, Inc. 23.84
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 0.8905
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.51
AVNS Avanos Medical, Inc. 12.35
AXDX Accelerate Diagnostics, Inc. 0.5775
AXGN AxoGen, Inc. 16.4
AXNX Axonics, Inc. 70.98
ETFs With Exposure to AVR
Ticker ETF Name Weight Percentage Price
IWN iShares Russell 2000 Value ETF 0.00276 144.65
IWO iShares Russell 2000 Growth ETF 0.00172 252.41
IWC iShares Micro-Cap ETF 0.01513 110.33
VTWV Vanguard Russell 2000 Value Index Fund 0 127.4
VTWG Vanguard Russell 2000 Growth Index Fund 0 184.33
VTWO Vanguard Russell 2000 Index Fund 0 78.45
RSSL Global X Funds 0 76.2355
Unlock